SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-030186
Filing Date
2021-06-01
Accepted
2021-06-01 13:22:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.16 TO SCHEDULE 13G ea141996-sc13ga16etf_corbus.htm SC 13G/A 45969
  Complete submission text file 0001213900-21-030186.txt   47538
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88716 | Film No.: 21984314
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901
Business Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901 908-897-0513
ETF MANAGERS GROUP, LLC (Filed by) CIK: 0001645173 (see all company filings)

IRS No.: 383938178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A